Normal Saline (Rocuronium 0 mg/kg)
OtherNormal saline is administered intravenously as the control study drug before video LMA insertion.
NCT Number: NCT07828977
This prospective, randomized, double-blind study aims to evaluate the effect of different degrees of neuromuscular blockade on the performance of a video laryngeal mask airway (LMA) during general anesthesia. Participants will be randomly assigned to receive rocuronium at 0, 0.3, or 0.6 mg/kg, corresponding to 0, 1, or 2 times the ED95, respectively. The primary outcome is oropharyngeal leak pressure measured after LMA insertion. Secondary outcomes include LMA insertion conditions, insertion time and number of attempts, laryngeal view, respiratory parameters, and postoperative airway-related complications.
Trial opening soon.
Get Notified20 year–65 year
All sexes
Interventional
Phase 4
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Normal saline is administered intravenously as the control study drug before video LMA insertion.
Rocuronium 0.3 mg/kg (1 × ED95) is administered intravenously before video LMA insertion.
Rocuronium 0.6 mg/kg (2 × ED95) is administered intravenously before video LMA insertion.
Time frame: 5 minutes after successful video LMA insertion
Oropharyngeal leak pressure will be measured 5 minutes after successful video LMA insertion and compared among the three neuromuscular blockade groups. OLP is expressed in cmH2O.
Time frame: 15 and 30 minutes after successful video LMA insertion
Time frame: During anesthetic induction before surgery, assessed for up to 5 minutes
The number of attempts required for successful video LMA insertion will be recorded. A maximum of two insertion attempts is permitted. Failure will be recorded if successful insertion is not achieved after two attempts.
Time frame: During anesthetic induction before surgery, assessed for up to 5 minutes
LMA insertion time will be measured in seconds from mouth opening to confirmation of the first capnographic waveform.
Time frame: Immediately after successful video LMA insertion
The laryngeal view obtained through the video LMA will be graded on a 4-point scale. The need for real-time adjustment and any change in laryngeal view after adjustment will also be recorded.
Time frame: Immediately before video LMA insertion
Neuromuscular response will be recorded immediately before video LMA insertion using train-of-four monitoring, including TOF count and/or quantitative twitch response according to the available monitor.
Time frame: Postoperatively in the PACU and at 24 hours after surgery
The presence or absence of sore throat, hoarseness, and dysphagia will be assessed separately for each participant.
Contact information is provided by the study sponsor or research team.
Korea University Guro Hospital
Other
The Relationship Between the Degree of Neuromuscular Blockade and the Conditions of Laryngeal Mask Ventilation: A Prospective Randomized Double-Blind Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07823179
Airway Management, General Anesthesia
View Trial DetailsNCT07581665
Airway Management, General Anesthesia
Guangzhou, Guangdong, China
View Trial DetailsNCT07699653
Airway Management, General Anesthesia
Guangzhou, Guangdong, China
View Trial DetailsNCT04381949
Airway Management, Atelectasis
Rouen, France
View Trial Details